For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
According to the WHO, cardiovascular disease is one of the leading cause of death worldwide. It is estimated that around 17.5 million people died from cardiovascular disease, which accounted for 31% of all global deaths in 2012. Cardiovascular disease can be prevented by addressing behavioral risks such as obesity, cigarette smoking, and an unhealthy diet. CRT device is an implantable medical device that are used to resynchronize the contractions of the heart's ventricles by sending tiny electrical impulses to the heart muscle, to pump the blood more efficiently.
Scope of the Report:
This report focuses on the Cardiac Resynchronization Therapy (CRT) Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
One of the various factors that back the market growth of cardiac resynchronization therapy devices market is the expanding pool of aging and geriatric patients worldwide. That segment of the human population is more vulnerable to chronic illness and is, as such, expected to generate the immense need for these resynchronization therapy gadgets so as to facilitate and accelerate sound heart activity. Other than cardiac arrest, there are some other medical conditions like atrial fibrillation, congenital heart disease, and arrhythmias which also require the implementation and usage of these cardiac resynchronization therapy devices.
Growing prevalence of various cardiovascular diseases like cardiac arrest, sick sinus syndrome, and bradycardia are also bolstering the growth of market. To diminish the rate of mortality arising out of cardiovascular illness, many hospitals have already initiated the use of CRT-Ps for managing the failures of heart. Furthermore, many doctors are increasing the usage of surgeries that are minimally invasive (MI) for various CRT-Ps implantation. These procedures are considered safe, diminish the blood transfusion requirement. It also decreases chances of infections and reduces stay at the hospital. This eventually accelerates the recovering and process thereby leading to much improved clinical outcome. This change in inclination towards minimally invasive procedures for the purpose of CRT-Ps implantation is poised to trigger the sales of the cardiac resynchronization therapy devices in the years to come.
The North American region is expected to contribute the highest revenue over the forecast period due to rising approvals by the U.S. FDA for new products and increasing growth of geriatric population suffering from cardiac dysfunction. As of 2016, it held more 36.0% of the global market share. Europe also held a substantial share and is predicted to witness lucrative growth with CAGR of more than 7.4% over the next nine years. Higher stringency being implemented by the healthcare agencies toward R&D, safety guideline follow-up, and product approvals are expected to drive the growth.
The worldwide market for Cardiac Resynchronization Therapy (CRT) Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Boston Scientific
- St. Jude Medical
- Cook Medical
- Sorin Group
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
- Healthcare Industry
- Cardiovascular industry
There are 15 Chapters to deeply display the global Cardiac Resynchronization Therapy (CRT) Devices market.
Chapter 1, to describe Cardiac Resynchronization Therapy (CRT) Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cardiac Resynchronization Therapy (CRT) Devices, with sales, revenue, and price of Cardiac Resynchronization Therapy (CRT) Devices, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cardiac Resynchronization Therapy (CRT) Devices, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cardiac Resynchronization Therapy (CRT) Devices market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cardiac Resynchronization Therapy (CRT) Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source